Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children

Mass immunization of children has the potential to decrease infection rates and prevent the transmission of influenza. We evaluated the immunogenicity, safety, and tolerability of different formulations of cell-derived MF59-adjuvanted and nonadjuvanted A/H1N1 influenza vaccine in children and adoles...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Knuf, Markus, Leroux-Roels, Geert, Rümke, Hans, Rivera, Luis, Pedotti, Paola, Arora, Ashwani Kumar, Lattanzi, Maria, Kieninger, Dorothee, Cioppa, Giovanni Della
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
INFLUENZA/Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514327/
https://ncbi.nlm.nih.gov/pubmed/25621884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.987014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados